Dear Editor, Lipopolysaccharide (LPS) interacts with immune cells by binding to CD14 molecules and then interacts with toll-like receptor (TLR)-4 on monocytes and dendritic cells [1–3]. On the other hand, TLR8 recognizes viral single-stranded RNA (ssRNA) [4]. Therefore, TLR4 is involved in immunological events during bacterial infection, and TLR8 is involved in immunological events during viral infection. Ciprofloxacin (CIP), a fluorinated 4-quinolone, is one of the quinolone antibiotics. CIP reduces the population of intestinal bacteria and influences the development of acute graft-vs-host disease (GVHD) after allogeneic bone marrow transplantation for hematological malignancies [5]. In addition, CIP has modulatory actions on immune and inflammatory responses, such as inhibition of the production of tumor necrosis factor (TNF)-α in LPS-stimulated peripheral blood mononuclear cells (PBMC) [6]. The mechanisms underlying the effects of quinolones on immune modulation might depend on the regulation of intracellular cAMP and NF-kB. CIP induces the production of prostaglandin E2 and increases intracellular cAMP levels. A hyperresponse to LPS by monocytes induces symptoms of septic shock, and CIP might therefore contribute to the attenuation of these symptoms after severe infection [7]. Cord blood contains more naive T cells and Treg precursor cells than adult blood [8]. In addition, it has been reported that there is a profound defect in IL-12 (p70) synthesis and an increased release of IL-10 in cord blood exposed to LPS compared to those in adult blood [9]. These facts might be relevant to the increased vulnerability of human newborns to intracellular pathogens and the low incidence of GVHD after cord blood transplantation (CBT). In this study, we analyzed TLR4, TRL8, ICAM-1, and LFA-1 expression on the surface of CD14-positive monocytes and TLR4, TLR8, and TNF-α mRNA expression after LPS stimulation with CIP using adult PBMC and cord blood mononuclear cells (CB). Normal adult PBMC and cord blood units were obtained from healthy donors with informed consent from Hokkaido Red Cross Blood Center Sapporo. Cells (1×10/ml) were cultured for 3 days with 10 μg/ml LPS (Escherichia coli 055: B5, EMD Bioscience, La Jolla, CA, USA) in RPMI-1640 with 10% fetal calf serum in the presence or absence of 50 μg/ ml CIP (kindly provided by Bayer Yakuhin, Osaka, Japan). After 3 days of culture, cells were harvested and stained with FITC-conjugated anti-TLR4 (HTA125; Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-LFA-1 (HI111; Becton Dickinson, San Diego, CA, USA), and anti-ICAM-1 (84H10; Immunotech, Marseille, France) monoclonal antibody (mAb) and with FITC-conjugated goat anti-mouse Ig G1 (STAR81F; Serotec, Oxford, UK) as a secondary antibody for anti-TLR8 (44C143; IMGENEX, San Diego, CA, USA) mAb and PEconjugated anti-CD14 (MoP9; Becton Dickinson) mAb. Mean fluorescence intensity (MFI) for TRL4, TRL8, ICAM-1, and LFA-1 on CD14-positive monocytes was analyzed using a fluorescence-activated cell sorter (FACS) Ann Hematol (2008) 87:229–231 DOI 10.1007/s00277-007-0363-x
Read full abstract